Chemoembolization Plus Radiotherapy versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis

A combination of transarterial chemoembolization (TACE) plus sorafenib or radiotherapy (RT) has demonstrated efficacy in patients with advanced hepatocellular carcinoma (HCC). Here, the two combined treatment approaches were compared in patients with HCC and portal vein tumor thrombus (PVTT). Data f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Hee Ho, Kim, Jin Hyoung, Shim, Ju Hyun, Yoon, Sang Min, Kim, Pyeong Hwa, Alrashidi, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281632/
https://www.ncbi.nlm.nih.gov/pubmed/32365655
http://dx.doi.org/10.3390/cancers12051116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281632/
https://www.ncbi.nlm.nih.gov/pubmed/32365655
http://dx.doi.org/10.3390/cancers12051116

Ejemplares similares